Shusuke Koto, Norio Chihara, Kyoka Shiroma, Asato Tsuji, Kimitaka Katanazaka, Shota Nishii, Kento Matoba, Ritsu Akatani, Masaya Togo, Kenji Sekiguchi, Riki Matsumoto (Division of Neurology, Kobe University Graduate School of Medicine, Japan)
Session information
Oral Session
Japanese
[O-05] Oral Session 05 [Japanese]「Neuroimmunology 1」
Wed. May 29, 2024 3:35 PM - 5:05 PM Room10 (G502, Glass Building, 5F, TIF)
Chair(s): Ichiro Nakashima (Tohoku Medical and Pharmaceutical University, Japan)
Masaaki Niino1, Shoko Fukumoto2, Yusei Miyazaki1, Nobuo Sanjo3, Takashi Ohashi4,5, Hideyuki Takeuchi6,7, Juichi Fujimori8, Tatsusada Okuno9, Hikoaki Fukaura10, Yuko Shimizu11, Eri Takahashi1, Nobuhiro Mifune12 (1.Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Japan, 2.Department of Neurology, Kyushu University, Japan, 3.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan, 4.Department of Neurology, Kamagaya General Hospital, Japan, 5.Department of Neurology, Tokyo Women's Medical University Yachiyo Medical Center, Japan, 6.Department of Neurology, Graduate School of Medicine, International University of Health and Welfare, Japan, 7.Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan, 8.Division of Neurology, Tohoku Medical and Pharmaceutical University, Japan, 9.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 10.Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan, 11.Department of Medical Safety and Department of Neurology, Tokyo Women's Medical University School of Medicine, Japan, 12.School of Economics and Management, Kochi University of Technology, Japan)
Katsuichi Miyamoto1, Norimitsu Inoue2, Hidefumi Ito1 (1.Department of Neurology, Wakayama Medical University, Japan, 2.Department of Molecular Genetics, Wakayama Medical University, Japan)
Chihiro Fujii1,2, Yuta Kojima2, Shinji Ashida2, Kumi Ishii1, Yuya Shinoto1, Kenji Yoshinaga1, Rie Tohge1, Masaki Takata1, Ryusei Nishigori1, Mio Hamatani1, Yusuke Yakushiji3, Takayuki Kondo1 (1.Department of Neurology, Kansai Medical University Medical Center, Japan, 2.Department of Neurology, Kyoto Prefectural University of Medicine, Japan, 3.Department of Neurology, Kansai Medical University, Japan)
Ritsu Akatani, Norio Chihara, Atsushi Hara, Asato Tsuji, Shusuke Koto, Riki Matsumoto (Division of Neurology, Kobe University Graduate School of Medicine, Japan)
Naoya Yamazaki1, Tatsuro Misu1, Naoki Yamamoto1, Shu Umezawa1, Naohiro Sakamoto1, Chihiro Namatame1, Yuki Matsumoto1, Hirohiko Ono1, Kimihiko Kaneko1, Yoshiki Takai1, Hiroshi Kuroda1,2,3, Kazuo Fujihara1,2,3, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Multiple Sclerosis &Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan)